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sensu stricto or B. burgdorferi sensu 
lato was detected (4/12 sites each), 
prevalence was 0.6%–2.2% and 0.7%–
2.5%, respectively. B. miyamotoi was 
detected at 7/12 sites, and prevalence 
ranged from 0.7% to 7.5%. A previous 
survey of B. burgdorferi in nearby San-
ta Cruz County recreational areas re-
ported an infection prevalence of ≈6% 
among adult I. pacificus ticks (6); the 
study did not, however, differentiate be-
tween Borrelia spp. and therefore may 
have included B. miyamotoi among its 
prevalence measures (5). In our study, 
B. burgdorferi was found more fre-
quently in woodland habitats, but it was 
also detected in a grassland–chaparral 
habitat several hundred meters from the 
nearest woodland. We did not detect B. 
bissettii, a species recently implicated 
as a human pathogen in Mendocino 
County, California (10). The high level 
of habitat variation in northwestern 
California presents a varied risk for 
Borrelia-associated tick-borne disease 
in humans because of diverse varia-
tions in vertebrate reservoir ecology, 
tick abundance, and human exposure 
to ticks. This variation emphasizes the 
need to understand the local epidemiol-
ogy and ecology of a disease.
In adult I. pacificus ticks in the 
San Francisco Bay area, B. miyamotoi 
is as abundant as its congener B. burg-
dorferi. Human disease caused by B. 
miyamotoi infection has not been re-
ported in California, and transmission 
efficiency of B. miyamotoi by I. paci-
ficus ticks is unknown. However, it is 
possible that B. miyamotoi infections 
in ticks and humans have not been ac-
curately diagnosed. We advocate for 
increased scrutiny of the eco-epidemi-
ology of B. miyamotoi in human, tick, 
and possible vertebrate host popula-
tions in northwestern California.
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Buruli Ulcer in  
Liberia, 2012
To the Editor: Buruli ulcer, a nec-
rotizing skin disease caused by Myco-
bacterium ulcerans, is highly endemic 
to West Africa (1,2) and is character-
ized by large ulcerations on the lower 
limbs (60% of cases) as well as on the 
upper limbs (30%) and other parts of 
the body (10%). Although the mode of 
transmission is unknown, most cases 
of Buruli ulcer occur around swampy 
and riverine areas; children <15 years 
of age are most often affected (2,3). 
The recommended treatment consists 
of a combination of daily oral rifampin 
and intramuscular streptomycin for 8 
weeks, supplemented by wound care 
when appropriate (4). Large ulcers 
may require debridement and grafting 
to facilitate wound closure, and phys-
iotherapy is often indicated to prevent 
functional limitation, particularly for 
lesions located over joints.
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In Liberia, 2 Buruli ulcer patients 
were reported in 1981 in the Foya re-
gion, along the Manor River basin; 
4 more patients were observed in the 
same area in 1984 (5). Since then, some 
patients from Liberia have received 
treatment for Buruli ulcer in Côte 
d’Ivoire (6), and suspicious cases have 
been detected in some parts of Liberia 
since the end of a civil war in 2004. 
Recently, Buruli ulcer cases have 
been suspected in 3 counties of Libe-
ria, Bong, Lofa, and Nimba; these re-
gions share borders with the Buruli ul-
cer–endemic regions of Côte d’Ivoire 
and Guinea. During 2012, the govern-
ment of Liberia, with assistance from 
the Medical Assistance Program In-
ternational and with technical support 
from the World Health Organization 
(WHO), conducted a rapid status as-
sessment in these 3 counties. In Janu-
ary 2012, a core team of national and 
county health personnel was trained in 
the recognition and assessment of Bu-
ruli ulcer. Assessment was conducted 
during February 18–27, 2012, by a 
team made up of those who had re-
ceived the preassessment training and 
WHO Buruli ulcer consultants.
During the preassessment training, 
notice was given to all health facilities 
to record all lesions with features sug-
gestive of Buruli ulcer. The persons 
identified during this period then came 
to the nearest health facility to be ex-
amined by the assessment team or were 
traced to their homes. A detailed his-
tory was collected and physical exami-
nation conducted, and swab specimens 
and fine-needle aspirates (2 for each le-
sion) were obtained for confirmation of 
diagnosis by classical PCR (7).
On the basis of the WHO case 
definition for Buruli ulcer (1), 60 of 
181 persons screened were suspected 
to have Buruli ulcer. All cases were 
documented by photography and reg-
istration on a modified version of the 
WHO Buruli ulcer assessment form 
(1). For 21 (35%) of the 60 patients, 
IS2404 PCR testing at Komfo Anokye 
Teaching Hospital in Ghana confirmed 
the clinical diagnosis; these patients 
received the recommended treatment 
for Buruli ulcer. Those with negative 
test results received wound care and 
supportive management. 
A total of 21 confirmed cases oc-
curred: 9 in Nimba County, and 6 each 
in Bong and Lofa Counties (Figure). 
Nine (35%) of the 21 patients were 
children <15 years of age; 11 patients 
were male and 10 female. Most (17 of 
21) lesions were on the lower limbs; 
3 were on the upper limbs and 1 on 
the thorax. Fifteen patients had ulcers, 
2 edema, and 3 osteomyelitis. No le-
sions were classified as category I, but 
11 (52.4%) were category III.
Our findings suggest that Buruli 
ulcer in Liberia may be more preva-
lent than previously thought. Although 
only 3 of 15 counties were assessed, 
results show that Buruli ulcer has not 
disappeared from Liberia and that the 
absence of regular reporting should 
be investigated. A long civil war and 
lack of familiarity with the disease by 
health care workers may have contrib-
uted to poor reporting.
It has been almost 3 decades since 
the last published report of Buruli ul-
cer cases in Liberia (5), but other stud-
ies have found the disease in countries 
many years after it was last reported. 
In Cameroon, a case search in 2001 in 
2 districts where cases had last been 
reported 24 years earlier found 436 
active and inactive cases (8). In south-
western Nigeria, a case search in 2006 
found 14 active and inactive cases 30 
years after the most recent publication 
(9). More recently, in 2012, a similar 
situation was reported in Gabon (10).
Several measures might improve 
Buruli ulcer control and surveillance 
in Liberia. First, treatment and con-
trol activities should be included in 
the Neglected Tropical Diseases Con-





surveillance. Second, health workers 
at all levels should be trained to rec-
ognize the disease. Third, a detailed 
assessment of the extent of Buruli ul-
cer in the 3 counties visited as well as 
in other counties should be prepared. 
Fourth, partner/donor support for 
Buruli ulcer activities should be en-
hanced. Fifth, capacity of the National 
Reference Laboratory to be able to 
perform PCR for confirmation of Bu-
ruli ulcer cases should be expanded. 
Last, Buruli ulcer should be incorpo-
rated into the national surveillance 
system to enable better data collection.
MAP International (employer of J.A. 
and F.Z.) provided financial assistance for 
the assessment in the counties.
Karsor Kollie,  
Yaw Ampem Amoako,  
Julien Ake, Tarnue Mulbah, 
Fasseneh Zaizay,  
Mohammed Abass,  
Linda Lehman, Albert Paintsil, 
Fred Sarfo, Clement Lugala, 
Alexandre Tiendrebeogo, 
Richard Phillips,  
and Kingsley Asiedu












Monrovia	 (C.	 Lugala);	 WHO,	 Brazzaville,	




  1. Asiedu K, Raviglione M, Scherpbier R, 
editors. Buruli ulcer: Mycobacterium 
ulcerans infection. Geneva: World Health 
Organization; 2000. WHO/CDS/CPE/
GBUI/2000.1.
  2. Buruli ulcer disease. Mycobacterium 
ulcerans infection: an overview of report-
ed cases globally. Wkly Epidemiol Rec. 
2004;79:194–9.
  3. Buruli ulcer: first programme review 
meeting for West Africa—summary re-
port. Wkly Epidemiol Rec. 2009;84:43–8.
  4. World Health Organization. Provisional 
guidance on the role of specific antibiot-
ics in the management of Mycobacterium 
ulcerans disease (Buruli ulcer). Geneva: 
The Organization; 2004. WHO/CDS/
CPE/GBUI/2004.10.
  5. Monson MH, Gibson DW, Connor DH, 
Kappes R, Heinz HA. Mycobacterium 
ulcerans in Liberia: a clinicopathologic 
study of 6 patients with Buruli ulcer. Acta 
Tropica. 1984;41:165–172.
  6. Kanga JM, Kacou DE. Epidemiological 
aspects of Buruli ulcer in Côte d’Ivoire: 
results of a national survey. Bull Soc 
Pathol Exot. 2001;94:46–51.
  7. Phillips RO, Sarfo FS, Osei-Sarpong F, 
Boateng A, Tetteh I, Lartey A, et al. 
Sensitivity of PCR targeting Mycobacte-
rium ulcerans by use of fine-needle aspi-
rates for diagnosis of Buruli ulcer. J Clin 
Microbiol. 2009;47:924–6. http://dx.doi.
org/10.1128/JCM.01842-08
  8. Noeske J, Kuaban C, Rondini S, Sorlin P, 
Ciaffi L, Mbuagbaw J, et al. Buruli ulcer 
disease in Cameroon rediscovered. Am J 
Trop Med Hyg. 2004;70:520–6.
  9. Chukwuekezie O, Ampadu E, Sopoh G, 
Dossou A, Tiendrebeogo A, Sadiq L, et al. 
Buruli ulcer, Nigeria. Emerg Infect Dis. 
2007;13:782–3. http://dx.doi.org/10.3201/
eid1305.070065
10. Ngoa UA, Adzoda GK, Louis BM, 
Adegnika AA, Lell B. Buruli ulcer 
in Gabon, 2001–2010. Emerg Infect 
Dis. 2012;18:1206–7. http://dx.doi.org/ 
10.3201/eid1807.110613
Address for correspondence: Yaw Amoako, 
Department of Medicine, Komfo Anokye 








To the Editor: Candidatus Neoeh-
rlichia mikurensis is a member of the 
order Rickettsiales, family Anaplasma-
taceae (1). Manifestations of infection 
with these bacteria are atypical and se-
vere and include cough, nausea, vomit-
ing, anemia, headache, pulmonary in-
filtration, malaise, myalgia, arthralgia, 
fatigue, recurrent fever for ≤8 months, 
and/or death (2–5). Candidatus N. mi-
kurensis has been detected in Ixodes 
ovatus, I. persulcatus, and Haemaphy-
salis concinna ticks in Asia (1,5).
Candidatus N. mikurensis has 
been identified as one of the most prev-
alent pathogenic agents in I. ricinus 
ticks throughout Europe (2,3,6). Ro-
dents of diverse species and geographic 
origins have been shown to carry these 
bacteria, but transmission experiments 
have not been conducted to unam-
biguously identify natural vertebrate 
reservoirs (1–3,5–7). This emerging 
tickborne pathogen has been detected 
mainly in immunocompromised pa-
tients in Sweden (n = 1), Switzerland (n 
= 3), Germany (n = 2), and the Czech 
Republic (n = 2) and in immunocom-
petent patients in China (n = 7) (2–5).
Anaplasma phagocytophilum is 
an obligate, intracellular, tickborne 
bacterium of the family Anaplasma-
taceae and causes granulocytic ana-
plasmosis in humans and domestic 
animals. In Europe, I. ricinus ticks are 
its major vector, and red deer, roe deer, 
rodents, and European hedgehogs (Er-
inaceus europaeus) are suspected res-
ervoir hosts (8).
Northern white-breasted hedge-
hogs (Erinaceus roumanicus) are urban-
dwelling mammals (order Eulipotyphla, 
family Erinaceidae) that serve as major 
maintenance hosts for the 3 stages of 
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